Diabetes researcher honoured with global recognition

Professor Fidelma Dunne, Professor of Medicine at University of Galway and Consultant Endocrinologist at Saolta University Health Care Group. Credit – Martina Regan.
Mar 11 2024 Posted: 14:48 GMT

Professor Fidelma Dunne becomes the first Irish person to receive Norbert Freinkel Award from American Diabetes Association

 

Leading diabetes researcher and Acting Director of the Institute for Clinical Trials at University of Galway, Professor Fidelma Dunne, has been recognised by the largest global diabetes research and educational organisation in the world, the American Diabetes Association.

Professor Dunne is being honoured for outstanding scientific achievement in the understanding and treatment of diabetes and pregnancy and lifelong dedication to advancing both clinical practice and clinical research in the field.

Professor Dunne said: “I am deeply honoured to receive the Norbert Freinkel Award from the American Diabetes Association. This recognition is a testament to the collaborative efforts of the research team at the University of Galway and the Institute for Clinical Trials and the broader Irish diabetes and endocrinology clinical and research community.

“It reflects not only my own dedication to advancing knowledge and treatment in the critical intersection of diabetes and pregnancy, but also the patients involved in the trial who place their trust in our team and our clinical research.”

Professor Dunne is Professor of Medicine at University of Galway and Consultant Endocrinologist at Saolta University Health Care Group and becomes the first Irish person to be recognised with the Norbert Freinkel Award from the American Diabetes Association.

The award recognises the value and impact of Professor Dunne’s research into gestational diabetes and healthcare for pregnant women and mothers, as well as a lifetime of contributions, both clinical and research, to the field of diabetes and pregnancy. This work culminated in the EMERGE trial published in JAMA: the Journal of American Medical Association, in 2023, which has alleviated concerns over metformin drug use for mothers with diabetes and their babies.

President of University of Galway, Professor Ciarán Ó hÓgartaigh said: “Professor Fidelma Dunne’s ground-breaking work in the field of diabetes and pregnancy positions her work here in Galway in an international setting and has significantly contributed to the global understanding of this complex condition. Her leadership and achievements reflect the excellence and commitment to research and clinical advancement at University of Galway.”

As part of the award, Professor Dunne will deliver the Award Lecture at the American Diabetes Association’s Scientific Sessions in Florida in June.

Ends

Marketing and Communications Office

PreviousNext

Featured Stories